欧洲神经精神药理学 SCIE

期刊简介预计审稿时间： 偏慢,4-8周

European Neuropsychopharmacology is the official publication of the European College of Neuropsychopharmacology (ECNP). In accordance with the mission of the College, the journal focuses on clinical and basic science contributions that advance our understanding of brain function and human behaviour and enable translation into improved treatments and enhanced public health impact in psychiatry. Recent years have been characterized by exciting advances in basic knowledge and available experimental techniques in neuroscience and genomics. However, clinical translation of these findings has not been as rapid. The journal aims to narrow this gap by promoting findings that are expected to have a major impact on both our understanding of the biological bases of mental disorders and the development and improvement of treatments, ideally paving the way for prevention and recovery.

《欧洲神经精神药理学》是欧洲神经精神药理学学院 (ECNP) 的官方出版物。根据学院的使命，该期刊专注于临床和基础科学贡献，以促进我们对大脑功能和人类行为的理解，并使其转化为更好的治疗方法和增强精神病学对公共卫生的影响。近年来，神经科学和基因组学的基础知识和可用的实验技术取得了令人振奋的进展。然而，这些发现的临床转化速度并不快。该期刊旨在通过宣传有望对我们理解精神障碍的生物学基础以及治疗方法的开发和改进产生重大影响的发现来缩小这一差距，理想情况下为预防和康复铺平道路。

《European Neuropsychopharmacology》(欧洲神经精神药理学)编辑部通讯方式为ELSEVIER SCIENCE BV, PO BOX 211, AMSTERDAM, NETHERLANDS, 1000 AE。如果您需要协助投稿或润稿服务，您可以咨询我们的客服老师。我们专注于期刊投稿服务十年，熟悉发表政策，可为您提供一对一投稿指导，避免您在投稿时频繁碰壁，节省您的宝贵时间，有效提升发表机率，确保SCI检索（检索不了全额退款）。我们视信誉为生命，多方面确保文章安全保密，在任何情况下都不会泄露您的个人信息或稿件内容。